Overview
Status
Active
Registry date
2015-09-09
Share capital
105,000.00 PLN
Registered address
ul. Sebastiana Klonowicza 25/2, 80-405 Gdańsk, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 297 days for 2022).
- 202515/07/2026
- 202415/07/2025
- 202304/11/2024
- 202207/05/2024
- 202111/12/2022
- 202013/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 40.04kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 5.84kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 32.85kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 1.12mMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Katarzyna Lewandowska – Attorney-in-fact (sole)
Monika Magdalena Pozorska – Attorney-in-fact (sole)
Rafał Tomasz Sobczyk – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Lewandowskaage 60 | 1,999 | $26,998.92 | 95.1905% |
Others | 101 | $1,364.13 | 4.8095% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-10-14.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 11, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Mimic Polandsp. z o.o. | $85,589.70 | mimic.com.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| Toto Pharma Polandsp. z o.o. | $66,269.14 | totopharma.com | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| Medyczniesp. z o.o. | $30,538.69 | medycznie.pl | ||
| Arjamedicalsp. z o.o. | $29,555.69 | arjamedical.com | ||
| Ortosilesiasp. z o.o. + limited partnership | $23,684.03 | ortosilesia.pl | ||
| Eduaidsp. z o.o. | $22,952.22 | eduaid.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-02 | Address change (Ul. Startowa 8, 80-461, Gdańsk → Ul. Sebastiana Klonowicza 25/2, 80-405, Gdańsk) | |
| 2019-12-17 | Address change (Ul. Sportowa 8, 80-461, Gdańsk → Ul. Startowa 8, 80-461, Gdańsk) | |
| 2019-11-27 | Address change (Ul. Stara Stocznia 2/6, 80-862, Gdańsk → Ul. Sportowa 8, 80-461, Gdańsk) | |
| 2019-09-02 | Name change (Investments Rs → Pharmaworld) | |
| 2019-09-02 | PKD change (Removed: 56, 85; Added: 10, 21) |
FAQ
The main business activity of Pharmaworld focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 9, 2015.
The headquarters is located at: ul. Sebastiana Klonowicza 25, 80-405 Gdańsk.
The share capital of the company is PLN 105,000 (approx. $28,363).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 40,035 in 2025, which is an increase of 33.8% compared to 2024.
Yes, the company recorded a net profit of USD 5,839 in 2025.
The largest operating cost category falls under external services. This category amounted to USD 19,382 in 2025, representing 59% of all operating expenses.
Last updated: 2026-09-02
